CAR-T cell ther­a­py for myas­the­nia gravis shows promise in small study by Carte­sian Ther­a­peu­tics

Dan­ny De­Ber­ry was start­ing to lose hope. For more than a decade, the North Car­oli­na forester had suf­fered from myas­the­nia gravis, a dis­ease where a per­son’s own im­mune sys­tem mis­tak­en­ly at­tacks and de­stroys the vi­tal junc­tions be­tween nerves and mus­cles.

What be­gan as dou­ble vi­sion prob­lems that left him see­ing two of every tree in the woods soon mor­phed in­to leg and arm weak­ness. A cou­ple of years ago, he could bare­ly walk from his house to his pick­up truck with­out hav­ing to stop and catch his breath. Just as de­pres­sion was sink­ing in, De­Ber­ry read about an ex­per­i­men­tal treat­ment called a CAR-T cell ther­a­py that might help him.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER